Industry: Pharmaceuticals, Biotechnology
TDT is a biotechnology company developing molecular-based technologies for the targeted detection, diagnosis and treatment of gastrointestinal cancers and infectious diseases. In August of 2003, TDT launched the first of several in vitro diagnostic products for the detection of metastatic colorectal cancer. The GCC-B1Ô Blood Test is used for monitoring patients for signs of recurrent colorectal cancer. Later this year, the Company plans to launch the GCC-N1Ô Node Test, a lymph node test for staging colorectal cancer. Both tests can detect 1 colorectal cancer cell in 10,000,000 normal cells, and represent a dramatic improvement in sensitivity and specificity over other test methodologies currently in ( www.tdtinc.com )
Targeted Diagnostics & Therapeutics , Inc
1045 Andrew Drive
West Chester, Pennsylvania 19380
USA
Tel: (610) 431-0800
Fax: (610) 431-0805